Kringle Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4884?
Owner TypeNumber of SharesOwnership Percentage
Public Companies300,0004.41%
Individual Insiders492,9007.25%
Private Companies600,8408.84%
Institutions736,41810.8%
General Public4,670,40668.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 21.1%.


Top Shareholders

Top 15 shareholders own 35.4% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.36%
Nippon Zenyaku Kogyo Co.,Ltd.
500,840JP¥423.2m0%no data
5.6%
SBI Holdings Inc., Asset Management Arm
380,586JP¥321.6m0%0.11%
3.07%
Tohoku University Venture Partners Co.,Ltd.
208,660JP¥176.3m0%23.21%
2.94%
CYBERDYNE Inc.
200,000JP¥169.0m0%no data
2.47%
Tetsuo Yamada
168,000JP¥142.0m0%no data
2.06%
Daisuke Gomi
140,000JP¥118.3m0%no data
1.75%
Rakuten Investment Management, Inc.
118,900JP¥100.5m0%0.04%
1.64%
Ueda Yagi Tanshi Co. Ltd., Asset Management Arm
111,800JP¥94.5m0%0.14%
1.57%
Yasunori Sasaki
107,000JP¥90.4m0%no data
1.52%
DBJ Capital Co., Ltd.
103,100JP¥87.1m0%3.42%
1.47%
Maruishi Pharmaceutical Co.,Ltd.
100,000JP¥84.5m0%no data
1.47%
ReproCELL Incorporated
100,000JP¥84.5m0%no data
1.33%
Keio Innovation Initiative Inc.
90,460JP¥76.4m0%34.65%
1.12%
Kiichi Adachi
75,900JP¥64.1m0%no data
0.029%
Daima Hayata
2,000JP¥1.7m0%no data